The CAR T-cell therapy equecabtagene autoleucel, or eque-cel, was shown in trial to improve walking ability for five progressive MS patients.

Progressive's profit engine looks built for the long haul -- and today's valuation gives investors a reasonable entry point.

Root, Inc.'s strong customer satisfaction & scalable technology support long-term growth potential. Click here to read why ROOT stock is a Strong Buy.

According to Consumer Reports, 60% of drivers say their car insurance premiums increased last year. But there's a big disparity from company to company.

A Pennsylvania court is putting Progressive's claims handling under the microscope after allegations of adjuster interference in settlement talks ...

Costs, Coverage and Trends.

Discover the 7 best car insurance apps to save time, cut costs, and simplify claims. Compare features, discounts & find the right fit for you.

Private auto insurers in the US continued to benefit from earned-in rate increases in the second quarter and again pushed premiums to record levels. Read more here.

Progressive Corp. is watching closely for the possibility of having to issue an excess profit refund to its policyholders in Florida, where it is the state's largest personal automobile insurer.

The recall election will be the city’s third in four years. It’s fueled by many of the same people who tossed out three liberal school board members in February 2022 followed by the ouster of ...